EAM
Empirical Asset Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
1,513
-2
| -0.1% | -$1.56K | 0.36% | 74 |
|
|
2025
Q1 | $1.25M | Sell |
1,515
-128,936
| -99% | -$106M | 0.43% | 55 |
|
|
2024
Q4 | $1.39M | Buy |
130,451
+80,301
| +160% | +$853K | 0.46% | 53 |
|
|
2024
Q3 | $1.41M | Buy |
50,150
+138
| +0.3% | +$3.88K | 0.5% | 48 |
|
|
2024
Q2 | $1.32M | Buy |
50,012
+48,255
| +2,746% | +$1.27M | 0.49% | 42 |
|
|
2024
Q1 | $364K | Buy |
1,757
+1,292
| +278% | +$267K | 0.18% | 168 |
|
|
2023
Q4 | $271K | Sell |
465
-181
| -28% | -$106K | 0.22% | 147 |
|
|
2023
Q3 | $347K | Buy |
646
+1
| +0.2% | +$537 | 0.3% | 114 |
|
|
2023
Q2 | $302K | Buy |
+645
| New | +$302K | 0.27% | 115 |
|
|
2022
Q1 | – | Sell |
-878
| Closed | -$243K | – | 172 |
|
|
2021
Q4 | $243K | Buy |
+878
| New | +$243K | 0.23% | 133 |
|